Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.

This study provides evidence that the peripheral administration of TPPU reduces hypernociception and inflammation in TMJ experimental arthritis. PMID: 32736189 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32736189?dopt=Abstract

Source: International Immunopharmacology - July 27, 2020 Category: Allergy & Immunology Authors: Teixeira JM, Abdalla HB, Basting RT, Hammock BD, Napimoga MH, Clemente-Napimoga JT Tags: Int Immunopharmacol Source Type: research